China’s 2023 Company Law Reform: Shifting the Accountability System for IPO Misrepresentation from Regulatory to Contractual Paradigms?

TY - JOUR

T1 - China’s 2023 Company Law Reform: Shifting the Accountability System for IPO Misrepresentation from Regulatory to Contractual Paradigms?

AU - Ye, Jiujing

AU - Lu, Lerong

PY - 2024

Y1 - 2024

N2 - In cases of misrepresentation, the mandatory disclosure of information by publicly listed companies is a legal obligation designed to enable informed investment decisions, uphold market integrity, and support broader societal goals. Currently, misrepresentation is governed by arts 89 and 163 of the Securities Law of the People’s Republic of China 2019 (PRC Securities Law 2019), which applies a tort law approach. Aggrieved investors may pursue private legal action, exemplifying a contractual accountability paradigm where market participants are expected to fulfil their roles. However, investors often face challenges, such as burdensome proof requirements, which limit the effectiveness of private actions even after the removal of administrative preconditions. In this context, intervention by the China Securities Regulatory Commission (CSRC) and institutions like the China Securities Investor Services Center Co Ltd (CSISC) is critical to ease the burden on investors. Administrative measures like “buybacks” and “advanced compensation” reinforce the system’s administrative tone. The 2023 revision of the Company Law of the People’s Republic of China (PRC Company Law 2023), which aims to strengthen individual liabilities, retains the tort-based logic of the PRC Securities Law 2019, failing to shift fully to a contractual paradigm. This paper recommends future revisions focus on clarifying the distinct roles of the PRC Securities Law 2019 and PRC Company Law 2023 in creating a “regulatory-contracting mixed paradigm” for accountability. Greater involvement of market professionals in misrepresentation cases would streamline compensation for primary market investors and mitigate future risks.

AB - In cases of misrepresentation, the mandatory disclosure of information by publicly listed companies is a legal obligation designed to enable informed investment decisions, uphold market integrity, and support broader societal goals. Currently, misrepresentation is governed by arts 89 and 163 of the Securities Law of the People’s Republic of China 2019 (PRC Securities Law 2019), which applies a tort law approach. Aggrieved investors may pursue private legal action, exemplifying a contractual accountability paradigm where market participants are expected to fulfil their roles. However, investors often face challenges, such as burdensome proof requirements, which limit the effectiveness of private actions even after the removal of administrative preconditions. In this context, intervention by the China Securities Regulatory Commission (CSRC) and institutions like the China Securities Investor Services Center Co Ltd (CSISC) is critical to ease the burden on investors. Administrative measures like “buybacks” and “advanced compensation” reinforce the system’s administrative tone. The 2023 revision of the Company Law of the People’s Republic of China (PRC Company Law 2023), which aims to strengthen individual liabilities, retains the tort-based logic of the PRC Securities Law 2019, failing to shift fully to a contractual paradigm. This paper recommends future revisions focus on clarifying the distinct roles of the PRC Securities Law 2019 and PRC Company Law 2023 in creating a “regulatory-contracting mixed paradigm” for accountability. Greater involvement of market professionals in misrepresentation cases would streamline compensation for primary market investors and mitigate future risks.

KW - Accountability System

KW - Misrepresentation

KW - IPO

KW - Investor Protection

KW - PRC Company Law 2023

KW - Corporate Law

KW - Capital Market

KW - Securities Regulation

M3 - Article

SN - 0958-5214

VL - 35

SP - 681

EP - 699

JO - International Company and Commercial Law Review

JF - International Company and Commercial Law Review

IS - 12

ER -